1. Introduction {#sec1}
===============

Since the introduction of the Kraepelinian dichotomy which divides major endogenous psychoses into two distinct groups of diseases that are known today as schizophrenia (SZ) and bipolar disorder (BD), this concept has strongly influenced modern psychiatric diagnostic classification systems. However, recent findings have cast doubt on this classification into two separate entities ([@bb0013]). Therefore, finding evidence of shared clinical features and/or pathophysiological pathways between these disorders represents a field of great interest in psychiatric neuroscientific research.

Direct comparisons of cognitive and clinical variables revealed that SZ and BD share important clinical and cognitive features ([@bb0033]; [@bb0041]), for example some symptoms of psychosis, memory deficits or affective disturbances. Episodic memory deficits are persistent in both disorders, even in symptom-free intervals ([@bb0033]; [@bb0041]). In BD however, the deficits are usually less severe than in SZ patients ([@bb0043]; [@bb0038]).

In addition to that, some anatomical alterations may be shared across psychosis disorders using multimodal imaging parameters (fibre integrity, volumes, cortical thickness) although the severity of the alterations or the location may be different. For instance, regarding volumetric findings, reduced hippocampal volume has been found frequently in SZ ([@bb0052]), but not as consistently in BD ([@bb001]; [@bb0025]; [@bb0042]; [@bb0016]). This is in line with reports of temporal, occipital and parietal volume and cortical thickness reductions in SZ but not in BD patients in comparison with controls ([@bb0039]). Regarding diffusion tensor imaging (DTI)-studies, current knowledge indicates partly analogical location of fibre integrity (FA) changes in SZ and BD: the recent meta-analysis of ([@bb0048]) yielded two regions with significant fibre integrity (FA) changes in SZ: the left frontal deep white matter and the left temporal deep white matter, and a meta-analysis in BD by [@bb0047] showed two significant right-hemispheric clusters of FA alterations that were located in the parahippocampal gyrus and close to the subgenual anterior cingulate cortex (ACC).

Functional imaging findings in both disorders suggest altered functional connectivity within frontal and between frontal and limbic regions in SZ ([@bb0034]; [@bb0028]) and a frontal--limbic network disturbance in BD ([@bb0053]; [@bb008]; [@bb0045]; [@bb0027]; [@bb0031]). Current findings in the field of resting-state fMRI support the idea that SZ and BD share core pathophysiological pathways. Resting-state fMRI is an attractive tool because it allows to measure functional activation independently of a specific task. A recent meta-analysis of resting-state studies in SZ showed decreased resting-state activity compared with control subjects in the left hippocampus, the ventromedial prefrontal cortex, the posterior cingulate cortex and the precuneus ([@bb0028]). In BD patients, altered functional connectivity between the frontal and the limbic brain ([@bb003]; [@bb0012]; [@bb0037]; [@bb0010]) and between the frontal cortex and the striatum ([@bb003]; [@bb0012]) has been reported.

In sum, the previous literature thus suggests that both disorders may share deficits in episodic memory and structural abnormalities in the hippocampus, although the results are less consistent in BD compared with SZ. Therefore, in the present study, we combined behavioral testing and structural imaging with resting-state fMRI which allowed us to probe the functional connectivity of the hippocampus with other parts of the brain.

In the current study we investigated the hypothesis that potential shared cognitive symptoms in SZ and BD are directly associated with functional and structural alterations within the hippocampal brain region.

2. Material and methods {#sec2}
=======================

2.1. Participants {#sec2.1}
-----------------

We included 21 patients with the diagnosis of a paranoid SZ (*M* \[mean\] = 38.38 years \[SD \[standard deviation\] = ±10.30\]) and 21 patients with the diagnosis of a BD I (mean age: *M* = 35.67 \[*SD* = ±10.68\] years) without any comorbid axis-I or II disorders (including drug abuse) according to the DSM-IV criteria ([@bb004]). We ensured the diagnosis using the Structured Clinical Interview for DSM-IV (SCID-I and SCID-II; German version ([@bb0049])) followed by an interview to examine sociodemographic factors. We only recruited remitted patients with BD. We ensured their remitted status by using the diagnostic criteria according to the DSM-IV ([@bb0049]). Also, we only included BP patients that scored less than 18 points in the German version of the Beck Depression Inventory II (BDI II ([@bb0022])) and less than 7 points in the German version of the Bech Rafaelsen Mania Scale (BRMAS; [@bb005]).

All patients were treated in the Department of Psychiatry, Goethe-University, Frankfurt, Germany during the time of the experiment. All patients were asked to participate in the current study during their treatment period, and we examined those patients who were willing to participate and who did not fulfil any exclusion criteria. To guarantee a good comparability between the two groups we ensured that the duration of illness (at a minimum of 5 years), the number of episodes of illness and the years of treatment with medication were comparable across disease groups (see [Table 1](#t0005){ref-type="table"} for further details). All patients had to be in a stable medication status (no significant change) during the last month preceding testing. We also computed chlorpromazine equivalents for each SZ patient using the formula by [@bb0051] and Almeida scores as described by [@bb002].

21 healthy participants (mean age: *M* = 36.90 \[*SD* = ±11.06\] years) who were matched with the patient groups in age, gender and education were included in the study. Exclusion criteria for control subjects were current drug-abuse, any kind of neurological disease, a history of psychiatric disorders including axis I and axis II disorders according to DSM-IV (using the SCID I and II ([@bb0049])), and an inability to provide informed consent. We ensured that none of the controls had any positive family history of affective or psychotic disorder. Statistical tests (ANOVA, Scheffé post-hoc contrast analyses, chi-square-tests) for differences between the groups regarding age, handedness and parental education revealed no significant group differences (all *p*-values \> 0.05).

The anatomical MRI scans of all participants were reviewed by a neuroradiologist who did not find any clinically relevant pathology. Participants were provided with a description of the study and gave written informed consent before participating. Experimental procedures were approved by the ethical board of the medical department of the Goethe-University, Frankfurt/Main, Germany.

### 2.1.1. Assessment of cognitive and clinical data {#sec2.1.1}

We assessed crystallized intelligence using the MWT-B (Mehrfachwahl-Wortschatz-Test ([@bb0029]), the German equivalent of the "Spot-the-Word test"), verbal learning with the Hopkins Verbal Learning Test-Revised \[HVLT-R\] and non-verbal (visual) learning using the Brief Visuospatial Memory-Test Revised \[BVMT-R\] (view [Table 2](#t0010){ref-type="table"} for further details) (all tests taken from the MATRICS test battery ([@bb0035])).

We explored the clinical state of the illness across patient groups using disease-specific questionnaires. For SZ patients, the Positive and Negative Syndrom Scale (PANSS ([@bb0024])) was administered. For BD patients, we used the BDI II ([@bb0022]) and the BRMAS ([@bb005]). This was done also for the healthy control group in order to rule out potential affective symptoms.

2.2. Data acquisition {#sec2.2}
---------------------

Within 1 week of the diagnostic, cognitive and clinical testing functional and anatomical images were acquired using a Siemens Magnetom Allegra 3 Tesla MRI system (Siemens Medical Systems, Erlangen, Germany) at the Goethe University Brain Imaging Center, Frankfurt am Main, Germany. Each scanning session began with a resting-state functional measurement (echo-planar-imaging \[EPI\]-sequence, 400 volumes, voxel size: 3 × 3 × 3 mm^3^, TR = 2000 ms, TE = 30 ms, 33 slices covering the whole brain, slice thickness = 3 mm, distance factor = 20%, flip angle = 90°), followed by a high-resolution T1-weighted anatomical measurement (MDEFT sequence ([@bb0088]), 176 slices, 1 × 1 × 1 mm^3^). Three diffusion tensor imaging datasets were also acquired for each subject using generalized auto-calibrating parallel acquisitions (GRAPPA; [@bb0019]) with an EPI sequence (TR = 8760 ms; TE = 100 ms; bandwith = 1302 Hz/pixel, acquisition voxel size = 2 × 2 × 2 mm^3^; 60 axial adjacent slices; slice thickness = 2 mm (no gap); FOV = 192 × 92 × 120 mm; acquisition matrix = 96 × 96; 10 images without diffusion weighting (b0) with 60 diffusion-encoded images (b-values = 1000 s/mm^2^ 60 noncolinear directions, acquisition time = 10 min.)).

Participants were scanned with dimmed lights and were instructed to lie still and look at a white fixation cross presented in the centre of the visual field. Participants did not engage in any overt speech during the scanning sequences.

2.3. Image preprocessing: resting-state fMRI {#sec2.3}
--------------------------------------------

The BrainVoyager QX software version 2.3 ([@bb0077]) was used to preprocess and co-register the functional and anatomical MR images. The preprocessing steps of the functional data included slice-time correction, rigid-body motion correction (Levenberg--Marquardt algorithm; cut-off for head motion: ±2 mm), linear trend removal and high-pass temporal filtering (3 cycles per time course, cutoff = 0.0075 Hz). Three-dimensional (3D) anatomical scans were transformed into Talairach space ([@bb0046]) using a 12-point affine transformation. We used automated routines of the BrainVoyager software to co-register the functional data to the anatomical scans of the same participant, and resampled the functional data to an iso-voxel size of 3 × 3 × 3 mm^3^.

For a seed-based analysis (SBA), we used an anatomically defined hippocampus mask (hippocampus total) provided by the Brain Voyager QX program. The seeds were then used to do a seed correlation analysis (SCA). During SCA, the functional time-series of one or more pre-defined brain areas (= seed regions) are sampled and correlated with all other functional time-series. Following previous recommendations, we corrected the seed time-series for potential nuisance variables (*Z*-normalized), which included fMRI signal from ventricles, white matter, the global (whole-brain) signal and the six head movement parameters ([@bb006]; [@bb009]). The analysing steps of the resting-state fMRI data were done with custom-written routines and freely available toolboxes in Matlab (MathWorks, Natick, MA). Results were visualized on the anatomical images using the BrainVoyager QX software.

2.4. Imaging preprocessing: ROI analysis with VBM {#sec2.4}
-------------------------------------------------

The VBM preprocessing and statistical analysis were performed with SPM8 (statistical parametric mapping \[Wellcome Department of Imaging Neuroscience, London, UK\]) running on MATLAB version 7.7.0. First, all images were checked for artefacts, structural abnormalities and pathologies. Second, customized T1 templates and prior images of grey matter (GM), white matter (WM) and cerebro-spinal fluid (CSF) were created from all participants in order to use it for the group analysis. We used modulated data and prior probability maps (voxel intensity) to guide segmentation in SPM. The segmentation included six different tissue types, light bias regularization (0.001), 60 mm bias FWHM cut-off, warping regularization of 4 mm, affine regularization to the ICBM European brain template (linear registration) and a sampling distance of 3 mm. The quality of the segmentation was checked before further analysis. Finally, the images were smoothed with a Gaussian kernel of 8 × 8 × 8 mm^3^ (FWHM). Using this procedure the intensity of each voxel was replaced by the weighted average of the surrounding voxels, in essence blurring the segmented image.

The WFU PickAtlas toolbox in SPM8 ([@bb0032]) was used to create masks for the left and right hippocampus. The size of the masks was 1000 mm^3^ (default). In the following step we compared grey matter volume differences in the ROIs between individual images, using the voxel-based morphometry (VBM) tool of the SPM8 software. Afterwards, group comparisons in the ROIs of GM using VBM were tested with linear statistical contrasts resulting in a *t*-statistic for each voxel. The respective global volumes of grey and white matter and CSF as obtained during segmentation were included as nuisance variables.

2.5. DTI procedures: ROI analysis with FSL {#sec2.5}
------------------------------------------

Diffusion MRI data were pre-processed and analysed using the standard TBSS routine of FSL 4.1 (Oxford Centre for Functional MRI of the Brain --- FMRIB software library; FSL, [[http://www.fmrib.ox.ac.uk/fsl]{.ul}](http://www.fmrib.ox.ac.uk/fsl){#interref1}) ([@bb0044]). TBSS is a specific voxel-wise approach to analyse DTI data, which projects individual DTI parameters of each participant onto a mean skeleton of a white matter mask ([@bb0044]). The different steps applied for the preprocessing of the Diffusion MRI data included motion correction, correction for eddy-current distortion and averaging the three DTI datasets into one single-4D dataset per subject. After that, the preprocessed images were fitted using a tensor model that generated the diffusion maps (fractional anisotropy \[FA\], mean diffusivity \[MD\]) used in the following TBSS analysis. This was followed by a non-linear registration of all images into standard MNI space and the creation of an averaged FA skeleton on which individual FA and MD values were projected (for further details of the procedure see [@bb0036]). The resulting DTI parameters on the skeleton were used for ROI analyses of all tracts which are connected to the grey matter regions of the hippocampus region. The tracts were selected using the JHU White-Matter Tractography Atlas provided by FSL ([@bb0023]). This Atlas tool is recommended by FSL and was used to mark the topographical boundaries of all ROIs in MNI space and to create white matter masks. The tracts were selected as follows: bilateral uncinate fasciculus, bilateral cingulum, fornix.

2.6. Statistical analysis {#sec2.6}
-------------------------

To generate a two-level general linear model (GLM) ([@bb007]; [@bb0040]), we sampled the averaged and normalized (Z-normalization) functional time-series of the predefined seed regions. This resulted in first-level functional connectivity coefficients for each participant. Then, the functional connectivity coefficients of the seed regions were entered into a second-level, mass-univariate one-way analysis of a covariance (ANCOVA) model. In this model the different groups were defined as a between-subject factor while the variables age, sex and education were considered as nuisance covariates. To correct for multiple comparisons, we used the FDR correction for main effect of functional connectivity (thresholded at *p* \< 0.05 ([@bb0018])). The effect of the group factor was then visualized on an anatomical template (courtesy of Montreal Neurologic Institute (MNI)). In a following step, all significant regions on this level were defined as regions-of-interest (ROIs), which were used for a ROI-averaged connectivity analysis (post-hoc, pairwise, two-sample *t*-test \[two-tailed\]) using voxel functional connectivity coefficients of each participant to assess group contrasts (corrected for multiple comparisons using the cluster-level correction tool (*p* \< 0.05; cluster-level correction, minimum cluster size of 200 mm^3^)).

The resulting statistical maps of the ROI grey matter analysis using VBM showed all voxels of the ROIs with a significant group difference being set at a (minimum cluster size = 100 mm^3^) *p*-value threshold of *p* \< 0.001 (small volume correction). The significant results of the analysis are interpreted as volume differences between the groups.

We also computed *t*-tests assessing group differences of ROI FA and MD values (bilateral uncinate fasciculus, fornix, bilateral cingulum) from the DTI analysis (at an alpha set at *p* \< 0.05; tfce \[threshold free cluster enhancement\] corrected), using the SPSS 21.0 software package (Statistical Package for Social Sciences, [[http://www.spss.com]{.ul}](http://www.spss.com){#interref2}).

Moreover, we performed group comparisons of cognitive measures (BVMT-R, HVLT-R) using two *independent ANOVAs* with group being a fixed factor and the test scores defined as independent variables. Group comparisons of BDI II and BRMAS were conducted using *t*-tests to compare the two groups (BD, CON). All comparisons of cognitive and neurobehavioral measures were conducted with the SPSS 21.0 software package.

We controlled for a potential influence of medication on the results performing a bivariate correlation analysis (Pearson product-moment correlation, two-tailed) between the functional connectivity values and the medication doses computed according to the method by [@bb002] for BD patients and chlorpromazine equivalents according to [@bb0051] for SZ patients. In addition, a correlation between the years of medication and the beta values of the functional activation during the resting-state measurement was calculated.

3. Results {#sec3}
==========

3.1. Cognitive and clinical data {#sec3.1}
--------------------------------

Mean (SD) PANSS scores in the group of SZ patients were: global scale: *M* = 63.20 (*SD* = ±5.20), positive symptoms: *M* = 15.40 (*SD* = ±3.00), negative symptoms: *M* = 15.11 (*SD* = ±1.90) and general symptomatology: *M* = 32.60 (*SD* = ±4.89) (see [Table 1](#t0005){ref-type="table"}).

Assessing current psychopathology in the groups of healthy control subjects (CON) and of the BD patients, we found that the BDI II scores of the BD patients were significantly higher compared to the control group (BD patients: *M* = 9.85 \[*SD* = ±8.97\], CON: *M* = 2.10 \[*SD* = ±3.45\]; *t* = 3.65, *p* = 0.001) indicating subclinical depressive symptoms in BD patients. BRMAS scores showed no significant group differences (BD patients: *M* = 0.38 \[*SD* = ±0.25\], CON: *M* = 0.25 \[*SD* = ±0.44\]; *t* = 0.83, ns). However, none of the patients or controls fulfilled a score of \>18 in the BDI II and a score of \>7 in the BRMAS, indicating acute symptoms.

Verbal (HVLT-R) and non-verbal (BVMT-R) learning parameters showed significant group differences across groups (HVLT-R: *F* = 17.76, *p* \< 0.001; BVLT-R: *F* = 14.89, *p* \< 0.001). Overall, SZ patients showed the lowest values followed by BD patients and controls. The group differences in both memory parameters reached a significant level in the post-hoc contrasts between controls and SZ patients and between BD patients and SZ patients (all *p* values \< 0.001). However, the group contrast between controls and BD patients showed significant differences only in the verbal learning values (HVLT; *p* \< 0.01). Controls, SZ and BD patients did not differ significantly in crystallized intelligence (*z* = −1.75, ns) (see [Table 1](#t0005){ref-type="table"}).

3.2. Resting-state functional connectivity {#sec3.2}
------------------------------------------

The multi-subject result map (voxel-by-voxel one-sample *t*-test of connectivity values) with voxel clusters of significant bilateral *hippocampus total* functional connectivity included left frontal lobe, right lentiform nucleus, right putamen, left thalamus, bilateral parahippocampal gyrus and bilateral cingulate gyrus (ANCOVA, *F*-map corrected for FDR).

### 3.2.1. Differences between SZ patients and controls {#sec3.2.1}

Post-hoc pairwise comparisons (two-sample *t*-tests, corrected for nuisance variables) showed a significant reduction of functional connectivity scores in the left frontal lobe, the right lentiform nucleus, the right putamen and the left thalamus in SZ patients compared with control subjects. Higher functional connectivity scores in SZ patients when compared with controls were found in the bilateral parahippocampal gyrus and in the bilateral cingulate gyrus (all *p*s \< 0.001; cluster-level correction; view [Fig. 1](#f0005){ref-type="fig"}, [Table 2](#t0010){ref-type="table"}).

### 3.2.2. Differences between BD patients and controls {#sec3.2.2}

Left frontal lobe functional connectivity was also decreased in BD patients in comparison with controls (*p* \< 0.001; cluster-level correction; view [Fig. 1](#f0005){ref-type="fig"}, [Table 2](#t0010){ref-type="table"}).

### 3.2.3. Graded differences (CON--BD--SZ) {#sec3.2.3}

If graded differences are defined as significant differences between all groups (SZ \> BD \> CON), none of the functional connectivity parameters fulfilled this criterion. However, in the left thalamus, BD patients showed mean values that lay between controls and SZ patients without showing statistically significant differences in comparison with the control group (view [Fig. 1](#f0005){ref-type="fig"}, [Table 2](#t0010){ref-type="table"}).

3.3. VBM results {#sec3.3}
----------------

The VBM ROI analysis of the left and right hippocampus revealed significant differences across groups (left: *F* = 11.77, right: *F* = 10.89, all *p*s \< 0.001).

### 3.3.1. Differences between SZ patients and controls {#sec3.3.1}

In the right hippocampal volumes SZ had significantly lower beta scores in comparison with controls. Differences in beta scores in BD as compared to controls did not reach a significant level (CON: *β* = −0.017 \[SD = ±0.04\], BD: *β* = −0.007 \[SD = ±0.05\], SZ: *β* = 0.031 \[SD = ±0.05\]).

### 3.3.2. Graded differences: CON--BD--SZ {#sec3.3.2}

In left hippocampal volumes, controls had the significantly highest beta scores, followed by BD patients and SZ patients (left: CON: *β* = −0.017 \[SD = ±0.009\], BD: *β* = −0.007 \[SD = ±0.009\], SZ: *β* = 0.030 \[SD = ±0.010\]; see [Fig. 2](#f0010){ref-type="fig"}, [Table 2](#t0010){ref-type="table"}).

3.4. DTI ROI results {#sec3.4}
--------------------

DTI ROI analyses revealed significant group differences in the cingulum bilaterally (MD), in the fornix (FA, MD) and the uncinate fasciculus bilaterally (FA, MD) (all *p*; tfce \< 0.05).

### 3.4.1. Differences in both patient groups in comparison with controls {#sec3.4.1}

Scheffé post-hoc single contrasts for the left and right cingulum showed the lowest values for MD in controls (all *p* (tfce) \< 0.05). Post-hoc group comparisons between the two patient groups showed significantly higher MD scores in SZ than in BD patients in the left cingulum, and -- the other way around -- for the right cingulum (highest MD scores in BD) (all *p* (tfce) \< 0.05).

After computing post-hoc single contrasts of the fornix we found significantly lower FA/higher MD values for both patient groups in comparison with controls (*p* (tfce) \< 0.05), but no significant group contrast between the patient groups (*p* (tfce) \> 0.05).

### 3.4.2. Differences between SZ patients and controls {#sec3.4.2}

In the left and right uncinate fasciculus, SZ patients showed lower FA values in comparison with controls (*p* \< 0.001).

### 3.4.3. Graded differences: CON--BD--SZ {#sec3.4.3}

A comparison of MD values in the bilateral uncinate fasciculus resulted in higher values in controls as compared to SZ patients (all *p*s (tfce) \< 0.05). BD patients showed trend level significance in the MD scores of the right uncinate fasciculus compared with controls (*p* = 0.10). Furthermore, in computing a direct comparison between the two patient groups, MD scores of the right uncinate fasciculus proved to be significantly increased in SZ patients in comparisons with BD patients. There was also trend level significance in the MD scores of the left uncinate fasciculus and the FA scores of the right uncinate fasciculus between SZ and BD patients (*p* \< 0.10) (see [Fig. 3](#f0015){ref-type="fig"}, [Table 2](#t0010){ref-type="table"}).

3.5. Correlation analyses {#sec3.5}
-------------------------

None of the clinical parameters separately assessed for each disease group (positive and negative symptoms in SZ \[PANSS\], acute affective symptoms \[BDI II for depressive, BRMAS for manic symptoms\]) showed a significant correlation with any of the functional or structural imaging parameters (all *p* values \> 0.05).

The BVMT-R (non-verbal learning) values were not significantly associated with any of the imaging parameters across groups (*p* \> 0.05). Verbal learning, however (measured using the HVLT-R) was significantly correlated with right hippocampus volumes in the BD (*r* = 0.490, *p* = 0.03) and in the SZ (*r* = 0.395, *p* = 0.04) patient groups (but not in controls; *p* \> 0.05). Yet these correlations did not reach significance after correcting for multiple comparisons (Bonferroni correction).

None of the imaging parameters showed any significant correlation with the medication scores or with years of medication in BD or SZ patients (*p* \> 0.05).

4. Discussion {#sec4}
=============

4.1. Resting-state functional connectivity {#sec4.1}
------------------------------------------

Our seed-based functional connectivity analysis (resting-state fMRI) with the bilateral hippocampus as the seed region revealed markers of hypo- and hyperconnectivity between hippocampal and fronto-limbic regions in both, SZ and BD patients, when compared with controls. In particular, SZ patients showed hypoconnectivity between the bilateral hippocampus, the left frontal lobe, the left thalamus, the bilateral lentiform nucleus and the right putamen. The results confirm current neurophysiological models that suggest altered functional connectivity within frontal and between frontal and limbic regions in SZ ([@bb0034]; [@bb0028]) and a frontal--limbic network disturbance in BD ([@bb0053]; [@bb008]; [@bb0045]; [@bb0027]; [@bb0031]). Accordingly, current resting-state findings in BD patients revealed changes in the functional connectivity between frontal and limbic brain regions in comparison with controls ([@bb003]; [@bb0012]; [@bb0037]; [@bb0010]) and fronto-striatal hypoconnectivity during rest in BD patients ([@bb003]; [@bb0012]).

Moreover, SZ patients showed higher functional connectivity scores in the bilateral parahippocampal gyrus and in the bilateral cingulate gyrus when compared with control subjects. The findings of disturbed connectivity in a fronto-limbic network with both -- hypo- and hyperconnectivity in SZ patients -- are in line with the theory of a disconnectivity syndrome in psychiatric disorders first proposed by [@bb0017] that suggested a failed connectivity between relevant brain regions. The result of either increased or decreased functional connectivities between the hippocampus and fronto-limbic brain regions shows the complex pattern of disturbance of brain networks in SZ. Furthermore, our findings in BD patients are in accordance with a recent meta-analysis (e.g., ([@bb0011])) which mainly suggests hyperactivity of limbic regions but not directly of the hippocampus in BD patients.

4.2. Volumetric (VBM) findings {#sec4.2}
------------------------------

Both SZ and BD patients showed lower grey matter volumes in the left hippocampus in comparison with controls; however volume deficits in the right hippocampus were limited to SZ patients. This is in-line with previous findings, which robustly show hippocampal volume reductions in SZ ([@bb0052]), but only inconsistently in BD ([@bb001]; [@bb0025]; [@bb0042]). Our findings therefore confirm the hypothesis of [@bb0066] that hippocampal volume may be of importance for the differentiation between SZ and BD. Brown and colleagues based their assumption on direct comparisons of grey matter volumes in subcortical regions, showing lower volumes in SZ patients compared with BD patients in the right hippocampus, in the putamen and the amygdala.

4.3. White matter fibre integrity/mean diffusivity (DTI) {#sec4.3}
--------------------------------------------------------

White matter fibre integrity, as assessed by mean diffusivity, was strongly affected in SZ patients in the tracts connecting the hippocampus with other brain structures (uncinate fasciculus, cingulum, fornix), whereas alterations in the BD patients were more subtle. This result is in line with findings of multiple white matter changes in SZ including the interconnections of the frontal lobe, thalamus, cingulate gyrus and white matter changes of the left temporal deep white matter (interconnections of frontal lobe, insula, hippocampus-amygdala, temporal lobe, occipital lobe) ([@bb0048]). Accordingly, in BD patients, mainly right-sided changes in DTI parameters have been reported (parahippocampal gyrus and close to the subgenual ACC) ([@bb0047]).

4.4. Graded differences: CON--BD--SZ {#sec4.4}
------------------------------------

Overall, the current data partly support the concept of graded changes across the SZ and BD spectrum. SZ patients show more pronounced deficits regarding neurobehavioral measures of episodic memory performance, alongside with stronger structural alterations when compared with BD patients. BD patients showed more subtle behavioral deficits in memory performance, and also more subtle functional and structural changes in comparison with controls. In a direct comparison, visual learning (HVLT), left hippocampal volume (VBM), mean diffusivity of the bilateral cingulum and the right uncinate fasciculus showed evidences for the idea that both patient groups are affected, but BD patients less severe. However, the resting state functional connectivity and other anatomical parameters did not support this concept of graded change.

The main finding of graded changes across the SZ and BD spectrum can be interpreted as partly contradictory to Kraepelin\'s ([@bb0026]) distinction of two entirely different and independent disease entities. However, our findings are in line with a large body of recent imaging and genetic research showing that BD and SZ share some core molecular and pathophysiological mechanisms ([@bb0013]; [@bb0014]) and thereby cannot be conceptualized as two entirely distinct classes of disorders. We may assume that BD and SZ may share some pathophysiological pathways but that there might be also distinct alterations across multimodal measures. Such an interpretation would conform with the findings from recent genome-wide association studies, which reveal partial but not complete overlap of the genetic risk profiles of these disorders ([@bb0021]).

4.5. Imaging parameters without graded changes {#sec4.5}
----------------------------------------------

Resting-state analysis revealed reduced functional connectivity in the left frontal lobe, the right lentiform nucleus, the right putamen and the left thalamus in SZ patients compared with control subjects, and higher functional connectivity scores in SZ patients when compared with controls in the bilateral parahippocampal gyrus and in the bilateral cingulate gyrus, but no alterations in BD patients. In contrast, left frontal lobe functional connectivity was decreased in BD patients in comparison with controls but not in SZ patients. Right hippocampal volumes might not be affected in BD patients but in SZ patients in comparison with controls. Regarding DTI parameters, mean diffusivity (MD) of fibre tracks related to the hippocampus showed graded changes, but this was less present in fibre integrity parameters (FA).

4.6. Cognitive and clinical data in association with imaging findings {#sec4.6}
---------------------------------------------------------------------

Clinical parameters specifically assessed for each disease group separately revealed no significant associations with the imaging findings. That means that our main findings are independent of acute symptomatology, including positive and negative symptoms in SZ \[PANSS\], and acute affective symptoms (BDI II for depressive, BRMAS for manic symptoms) in BD patients. However, our study was neither powered nor specifically designed to assess such correlations because our patient samples showed relatively low severity scores of acute symptoms.

Verbal learning (HVLT-R) scores showed significant group differences across groups, with the lowest values found for SZ patients and subtle deficits in BD patients in comparison with healthy controls. Crystallized intelligence did not differ across groups, and all main group differences in imaging parameters were independent of crystallized intelligence. Furthermore, verbal learning (HVLT-R) was significantly correlated with right hippocampal volumes in the BD and in the SZ patient groups although these comparisons did not last after correcting for multiple comparisons.

4.7. Limitations {#sec4.7}
----------------

Although all patients of our study were treated with psychiatric medication at the time of measurement, we tested potential influence of psychiatric medication on the functional and structural brain changes in our study. We failed to show any association between functional and structural parameters and medication status or duration of medication use. This result confirms previous findings that report no influence or even a positive effect (reduced group differences between patients and controls) of psychopharmacological treatment on structural and functional findings in psychiatric patients ([@bb0015]; [@bb0020]).

The sample size of the current study is relatively small, but we ensured that all patients were screened applying very strict inclusion criteria. For instance, we included only BD patients with BD I disorder (not BD II), we included only SZ patients with paranoid subtype (no schizoaffective or other subtype), and we ensured that none of the patients had any history of drug addiction.

5. Conclusions {#sec5}
==============

A direct comparison of SZ and BD, two major psychotic disorders, is of interest regarding the ongoing debate that was started with the introduction of the Kraepelinian dichotomy concept in 1896 ([@bb0026]). Currently this debate centres on the question whether BD and SZ are distinct disorders or may share some pathophysiological pathways. Our research suggests that although both examined patient-groups may share some pathophysiological pathways, functional and structural abnormalities may be more severe in SZ than in BD. Further studies are needed to explore and explain these graded changes in SZ and BD to define which parameters show graded changes and which do not.

The approach to examine functional as well as structural markers in the same study follows recent developments in the field ([@bb0050]), suggesting a mechanistic relationship between structural and functional abnormalities. Thus, the development of a multi-modal neurophysiological model of psychoses, with shared and distinct pathways across traditional disease entities, may help to clarify the pathways that contribute to individual symptom patterns ([@bb0030]).

MRI was performed at the Frankfurt Brain Imaging Centre, supported by the German Research Council (DFG) and the German Ministry for Education and Research (BMBF; Brain Imaging Center, Frankfurt/Main, DLR 01GO0203). The authors report no conflict of interest.

![Post-hoc comparisons (*t*-tests) of the functional connectivity between CON \> SZ, CON \> BD and BD \> SZ (t-map cluster-level corrected, *q* \< 0.05). Regions indicating significant group differences with hippocampus total as seed-region. CON = controls, BD = bipolar patients, SZ = schizophrenia. The left side in the figure indicates the right side of the brain (radiological convention). Colour codes: contrast CON \> SZ: red = higher functional connectivity scores in controls, blue = lower functional connectivity scores in controls (compared with SZ patients). Contrast CON \> BD: red = higher functional connectivity scores in controls, blue = lower functional connectivity scores in controls (compared with BD patients). Contrast BD \> SZ: red = higher functional connectivity scores in BD patients, blue = lower functional connectivity scores in BD patients (compared with SZ patients).](gr1){#f0005}

![Upper row: One-way ANCOVA (*F*-test fitted response) of the beta scores of the ROI VBM analysis of the hippocampus with group as between-subject factor and age, sex and education as covariates. Middle row: Beta scores across groups of left and right hippocampus across groups (colour code: white = CON, grey = BD, black = SZ). Lower row: *T*-tests of the group contrasts CON \> SZ, CON \> BD and BD \> SZ (statistical threshold: *q* \[small volume correction\] \< 0.001). The left side in the figure indicates the right side of the brain (radiological convention).](gr2){#f0010}

![Group comparisons in DTI ROI analyses, regarding the tracts cingulum (left and right, upper row), fornix (middle row) and uncinate fasciculus (left and right, lower row), with group as between-subject factor and FA, MD, RD and L1 scores as independent variables. Only those values which deemed significant during group comparisons have been shown here. Colour code: CON = black, BD patients (BD) = grey, SZ patients (SZ) = white.](gr3){#f0015}

###### 

Sociodemographic and clinical characteristics and cognitive performance of the SZ patient group (*n* = 21), the BD patient group (*n* = 21) and the control group (CON; *n* = 21). SD and range are in brackets.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                 BD                          SZ                               CON                Statistics
  ------------------------------ --------------------------- -------------------------------- ------------------ ----------------------------------------------------
  Number                         21                          21                               21                 --

  Gender\                        9 f/12 m\                   9 f/12 mSZ/CON:χ^2^ = 0.13, ns   8 f/12 m\          χ^2^ = Pearson\'s chi-square
  f/m                            BD/SZ:\                                                      BD/CON:\           
                                 χ^2^ = 0.18, ns\                                             χ^2^ = 0.11, ns\   

  Age (years)                    35.67 (10.68)               38.38 (10.30)                    36.95 (11.10)      *F* = 0.34, ns

  Education (years)              14.86 (2.43)                15.82 (4.92)                     15.85 (1.84)       *F* = 0.60, ns

  Handedness\                    80.75 (18.09)               76.34 (15.65)                    80.48 (15.91)      *F* = --0.45, ns
  (EHI) L:R                                                                                                      

  Duration of illness (yr.)      7.62 (5.82)                 8.45 (3.45)                      --                 *t* = 0.67, ns

  Episodes of illness (nr.)      6.35 (12.00)                4.32 (1.23)                      --                  *t* = 0.38, ns

  Medication (yr.)               6.26 (6.09)                 7.34 (3.78)                      --                 *t* = --1.45, ns

  Medication categories          21 mood stabilisers\        21 atypical neuroleptics\                           
                                 2: addit. antidepressants   5: addi. typical neuroleptics                       

  *Clinical scores*                                                                                              

  BDI II                         9.85 (8.97)                 --                               2.10 (3.45)        *t* = 3.65 [\*\*](#ngtbl1.1){ref-type="table-fn"}

  BRMAS                          0.38 (0.25)                 --                               0.25 (0.44)        *t* = 0.83, ns

  PANSS global                   --                          63.20 (5.20)                     --                 --

  PANSS positive                 --                          15.40 (3.00)                     --                 --

  PANSS negative                 --                          15.11 (1.90)                     --                 --

  PANSS general symptomatology   --                          32.60 (4.89)                     --                 --

  *Cognitive scores*                                                                                             

  HVLT-R (*t*-scores)            51.27 (12.46)\              38.56 (8.14)\                    56.56 (12.37)\     *F* = 17.76[\*\*](#ngtbl1.1){ref-type="table-fn"}\
                                                                                                                 Post-hoc:\
                                                                                                                 CON/BD[\*](#ngtbl1.0){ref-type="table-fn"}\
                                                                                                                 CON/SZ[\*\*](#ngtbl1.1){ref-type="table-fn"}\
                                                                                                                 SZ/BD[\*\*](#ngtbl1.1){ref-type="table-fn"}

  BVMT-R (*t*-scores)            54.91 (8.03)\               36.20 (14.61)\                   54.23 (10.89)      *F* = 14.89[\*\*](#ngtbl1.1){ref-type="table-fn"}\
                                                                                                                 Post-hoc:\
                                                                                                                 CON/BD: ns\
                                                                                                                 CON/SZ[\*\*](#ngtbl1.1){ref-type="table-fn"}\
                                                                                                                 BD/SZ[\*\*](#ngtbl1.1){ref-type="table-fn"}

  MWT-B                          29.86 (3.31)                28.01 (2.89)                     31.96 (2.91)       *z* = --1.75, ns
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------

Note: ns = non-significant. BDI II = Beck Depression Inventory, BRMAS = Bech Rafaelsen Mania Scale, PANSS = Positive and Negative Syndrome Scale, HVLT-R = Hopkins Verbal Learning Test-Revised \[HVLT-R\]), BVMT-R = Brief Visuospatial Memory-Test Revised \[BVMT-R\]), MWT-B  = Mehrfachwahl-Wortschatztest, EHI = Edinburgh Handedness Inventory. f = female, m = male.

*p* \< 0.01.

*p* \< 0.001.

###### 

A\) Post-hoc group comparisons between controls (*n* = 21), SZ patients (*n* = 21) and BD patients (*n* = 21) in the functional connectivity pattern between hippocampus bilaterally and whole-brain functional connectivity. B) Statistical test for group differences regarding the VBM beta scores in the hippocampus left and right (ROIs based on the hippocampus mask total). *T* scores were corrected for multiple comparisons using small volume correction ('svc'). Correction for multiple comparisons using additional FDR correction was noted as 'FDR'. The table only includes significant group comparisons. C) Statistical test for group differences regarding the DTI ROI analysis parameters (FA, MD, RD, L1) regarding the tracts: cingulum, fornix, uncinate fasciculus provided by the JHU White-Matter Tractography Atlas (provided by FSL ([@bb0023])).

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  ROI mask                                       Tal.\                                      CON\             BD\              SZ\                                         F\                                           BD\>SZ\                                    CON\>SZ\                                   CON\>BD\                                   
                                                 Koord. *x, y, z*\                          *M (SD)*\        *M (SD)*\        *M (SD)*\                                   signifi-cance                                *p*                                        *p*                                        *p*                                        
                                                 (cluster size, voxel)                      beta scores      beta scores      beta scores                                                                                                                                                                                                               
  ---------------------------------------------- ------------------------------------------ ---------------- ---------------- ------------------------------------------- -------------------------------------------- ------------------------------------------ ------------------------------------------ ------------------------------------------ -----------------------------------
  *A) Resting state*: *seed hippocampus total*                                                                                                                                                                                                                                                                                                          

  L. frontal lobe                                -19, -27, 26 (506)                         0.145 (0.013)    0.034 (0.012)    0.040 (0.015)                               F = 4.41[⁎](#tf0005){ref-type="table-fn"}    ns                                         [⁎](#tf0005){ref-type="table-fn"}          [⁎](#tf0005){ref-type="table-fn"}          

  L. frontal lobe                                -21, -47, 25 (475)                         0.102 (0.034)    0.056 (0.012)    0.051 (0.043)                               F = 3.23[⁎](#tf0005){ref-type="table-fn"}    ns                                         [⁎](#tf0005){ref-type="table-fn"}          [⁎](#tf0005){ref-type="table-fn"}          

  R. lentiform nucleus                           19, -11, 0 (964)                           0.071 (0.029)    0.055 (0.018)    0.045 (0.021)                               F = 3.10[⁎](#tf0005){ref-type="table-fn"}    ns                                         [⁎](#tf0005){ref-type="table-fn"}          ns                                         

  R. putamen                                     27, 6, 0 (587)                             0.092 (0.023)    0.078 (0.018)    0.068 (0.018)                               F = 4.51[⁎](#tf0005){ref-type="table-fn"}    ns                                         [⁎](#tf0005){ref-type="table-fn"}          ns                                         

  L. thalamus                                    -3, -6, 0 (617)                            0.068 (0.078)    0.061 (0.054)    0.047 (0.056)                               F = 3.18[⁎](#tf0005){ref-type="table-fn"}    [⁎](#tf0005){ref-type="table-fn"}          [⁎](#tf0005){ref-type="table-fn"}          ns                                         

  Bil. para-hippocampal gyrus                    -29, -35, -7 (639)                         0.081 (0.023)    0.079 (0.025)    0.101 (0.023)                               F=5.42[⁎⁎](#tf0010){ref-type="table-fn"}     [⁎](#tf0005){ref-type="table-fn"}          [⁎](#tf0005){ref-type="table-fn"}          ns                                         

  31, -21, -12 (885)                             0.031 (0.071)                              0.042 (0.623)    0.069 (0.653)    F = 2.99[⁎](#tf0005){ref-type="table-fn"}   ns                                           [⁎](#tf0005){ref-type="table-fn"}          ns                                                                                    

  Bil. cingulate gyrus                           -21, -25, -7 (415)                         0.045 (0.034)    0.058 (0.012)    0.078 (0.065)                               F = 6.01[⁎](#tf0005){ref-type="table-fn"}    ns                                         [⁎](#tf0005){ref-type="table-fn"}          ns                                         

  16, -19, -3 (338)                              0.067 (0.012)                              0.080 (0.018)    0.103 (0.065)    F = 8.67[⁎](#tf0005){ref-type="table-fn"}   ns                                           [⁎](#tf0005){ref-type="table-fn"}          ns                                                                                    

                                                                                                                                                                                                                                                                                                                                                        

  *B) VBM*                                                                                                                                                                                                                                                                                                                                              

  L. hippo-campus                                -28, -15, -25 (929)                        -0.017 (0.009)   -0.007 (0.009)   0.030 (0.010)                               F = 11.77[⁎](#tf0005){ref-type="table-fn"}   [⁎⁎](#tf0010){ref-type="table-fn"} (svc)   [⁎⁎](#tf0010){ref-type="table-fn"} (svc)   [⁎⁎](#tf0010){ref-type="table-fn"} (svc)   

  [⁎⁎](#tf0010){ref-type="table-fn"} (FDR)       [⁎⁎](#tf0010){ref-type="table-fn"} (FDR)   p = 0.09 (FDR)                                                                                                                                                                                                                                              

  R. hippo-campus                                21, -21, -24 (949)                         -0.017 (0.04)    -0.007 (0.05)    0.031 (0.05)                                F = 10.89[⁎](#tf0005){ref-type="table-fn"}   [⁎⁎](#tf0010){ref-type="table-fn"} (svc)   [⁎⁎](#tf0010){ref-type="table-fn"} (svc)   ns                                         

  [⁎⁎](#tf0010){ref-type="table-fn"} (FDR)       [⁎⁎](#tf0010){ref-type="table-fn"} (FDR)   ns                                                                                                                                                                                                                                                          

                                                                                                                                                                                                                                                                                                                                                        

  *C) DTI*                                                                                                                                                                                                                                                                                                                                              

  Cingulum                                       LH                                         FA               0.408 (0.201)    0.398 (0.023)                               0.401 (0.270)                                1.78, ns                                   \-                                         \-                                         \-

  MD                                             0.689 (0.031)                              0.705 (0.024)    0.734 (0.029)    16.80[⁎⁎](#tf0010){ref-type="table-fn"}     [⁎⁎](#tf0010){ref-type="table-fn"}           [⁎⁎](#tf0010){ref-type="table-fn"}         [⁎](#tf0005){ref-type="table-fn"}                                                     

  RH                                             FA                                         0.362 (0.176)    0.357 (0.214)    0.352 (0.263)                               2.22, ns                                     \-                                         \-                                         \-                                         

  MD                                             0.512 (0.041)                              0.685 (0.022)    0.609 (0.047)    27.47[⁎⁎](#tf0010){ref-type="table-fn"}     [⁎⁎](#tf0010){ref-type="table-fn"}           [⁎⁎](#tf0010){ref-type="table-fn"}         [⁎⁎](#tf0010){ref-type="table-fn"}                                                    

  Fornix                                                                                    FA               0.263 (0.277)    0.245 (0.337)                               0.241 (0.341)                                5.23[⁎](#tf0005){ref-type="table-fn"}      ns                                         [⁎](#tf0005){ref-type="table-fn"}          [⁎](#tf0005){ref-type="table-fn"}

  MD                                             1.458 (0.174)                              1.510 (0.154)    1.660 (0.145)    8.38[⁎⁎](#tf0010){ref-type="table-fn"}      ns                                           [⁎⁎](#tf0010){ref-type="table-fn"}         [⁎](#tf0005){ref-type="table-fn"}                                                     

  Uncinate fasciculus                            LH                                         FA               0.410 (0.273)    0.420 (0.231)                               0.376 (0.035)                                17.36[⁎⁎](#tf0010){ref-type="table-fn"}    [⁎⁎](#tf0010){ref-type="table-fn"}         [⁎⁎](#tf0010){ref-type="table-fn"}         ns

  MD                                             0.732 (0.032)                              0.735 (0.081)    0.771 (0.076)    3.69[⁎⁎](#tf0010){ref-type="table-fn"}      p = 0.07                                     [⁎](#tf0005){ref-type="table-fn"}          ns                                                                                    

  RH                                             FA                                         0.353 (0.166)    0.350 (0.268)    0.341 (0.219)                               3.71[⁎](#tf0005){ref-type="table-fn"}        p = 0.08                                   [⁎](#tf0005){ref-type="table-fn"}          ns                                         

  MD                                             0.726 (0.050)                              0.760 (0.083)    0.810 (0.040)    13.32[⁎⁎](#tf0010){ref-type="table-fn"}     [⁎⁎](#tf0010){ref-type="table-fn"}           [⁎⁎](#tf0010){ref-type="table-fn"}         p = 0.10                                                                              
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Note: BA = Brodmann area, TAL = Talairach coordinates, FC = functional connectivity scores, CON = controls, BD = bipolar patients, SZ = schizophrenia patients, FA = fractional anisotropy, MD = mean diffusivity (mm²/s × 10^−3^), RD = radial diffusivity (mm²/s × 10^−3^), L1 = axial diffusivity (mm²/s × 10^−3^).

*p* \< 0.01.

*p* \< 0.001.
